Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma

AIMS: To date, curative resection remains to be the most optimal therapeutic choice of hepatocellular carcinoma (HCC), though the overall survival (OS) remains extremely unsatisfactory. To better manage the HCC patients, we evaluated the prognosis predicting values of apolipoprotein B (ApoB) and low...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Onco Targets Ther
Autori principali: Yan, Xiaotong, Yao, Mingjie, Wen, Xiajie, Zhu, Yiwei, Zhao, Erjiang, Qian, Xiangjun, Chen, Xiangmei, Lu, Weiquan, Lv, Quanjun, Zhang, Ling, Lu, Fengmin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420103/
https://ncbi.nlm.nih.gov/pubmed/30881047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S192631
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi